The management of subcentimeter residual mass in NSGCT: PcRPLND vs. observation Journal Article


Authors: Daneshmand, S.; Stephenson, A. J.; Sheinfeld, J.; Jewett, M. A. S.
Article Title: The management of subcentimeter residual mass in NSGCT: PcRPLND vs. observation
Abstract: Patients with advanced non-seminomatous germ cell tumors may achieve a serologic and radiographic complete response (CR) to first-line chemotherapy (defined as a residual mass < 1 cm in size). Recent reports suggest that these patients may be observed with a low rate of relapse but there remain compelling arguments for surgical excision. The arguments for and against post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) are presented. There is clear consensus that patient's with residual masses > 1 cm should undergo post-chemotherapy surgery. © 2011 Elsevier Inc.
Keywords: cancer chemotherapy; cancer survival; cancer surgery; review; advanced cancer; follow up; antineoplastic agent; lymph node dissection; lymph node excision; tumor volume; neoplasm, residual; neoplasms, germ cell and embryonal; retroperitoneal neoplasms; testis cancer; germ cell tumor; retroperitoneum; retroperitoneal space; testis teratoma; post-chemotherapy retroperitoneal lymph node dissection; non seminomatous germ cell tumor
Journal Title: Urologic Oncology: Seminars and Original Investigations
Volume: 29
Issue: 6
ISSN: 1078-1439
Publisher: Elsevier Inc.  
Date Published: 2011-01-01
Start Page: 842
End Page: 847
Language: English
DOI: 10.1016/j.urolonc.2011.05.018
PROVIDER: scopus
PUBMED: 22078409
DOI/URL:
Notes: --- - "Export Date: 9 December 2011" - "CODEN: UOSOA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joel Sheinfeld
    254 Sheinfeld